Sarah Schram

Stock Analyst at William Blair

(n/a)
# 4,599
Out of 4,786 analysts
2
Total ratings
n/a
Success rate
-26.77%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sarah Schram

Denali Therapeutics
Jan 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $13.60
Upside: -
Vigil Neuroscience
Dec 4, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.78
Upside: -